Equities analysts expect Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) to post sales of $10.95 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have made estimates for Dicerna Pharmaceuticals’ earnings. The highest sales estimate is $14.95 million and the lowest is $6.93 million. Dicerna Pharmaceuticals reported sales of $1.55 million during the same […]
